Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, Minnesota 55902


This study is being done to learn the effects of the Pulmonary Vein Isolation in patients that are at high risk to developing, but do not have a documented history of atrial fibrillation.

Study summary:

Patients with a dilated left atrium (left upper chamber of the heart) that undergo mitral valve surgery may be at risk for the development of atrial fibrillation after surgery. Atrial fibrillation (also known as "A-Fib" or AF) is an abnormal heart rhythm which may cause symptoms such as pounding sensations in your chest, dizziness, fatigue, chest pain and/or shortness of breath. AF patients are at a higher risk of developing a stroke. Participants who sign informed consent will be randomized into one of two groups by chance (as in the flip of a coin). Approximately 77 patients will undergo their mitral valve operation along with Pulmonary Vein Isolation (a treatment group) and 77 patients who do not undergo Pulmonary Vein Isolation at the time of their mitral valve surgery (a control group). The treatment group will undergo operation for mitral valve disease with an additional procedure called Pulmonary Vein Isolation using a device that delivers radiofrequency energy to the heart muscle in order to create scar tissue to block electrical impulses that can trigger episodes of AF. The control group of patients will undergo operation for mitral valve disease without the additional Pulmonary Vein Isolation.


Inclusion Criteria: - Indication for open-heart surgery: Mitral valve repair or replacement, evidence of a dilated left atrium Exclusion Criteria: - History of Atrial Fibrillation - Need for emergent cardiac surgery - Previous cardiac surgery - Preoperative need for an intraaortic balloon pump or intravenous inotropes - Current diagnosis of active endocarditis - Mental impairment/or experience other conditions which may not allow subject to understand nature - Significance and scope of study - Pregnancy



Primary Contact:

Principal Investigator
Thoralf M. Sundt, III, M.D.
Professor of Surgery, Mayo Clinic

Backup Contact:


Location Contact:

Rochester, Minnesota 55902
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.